Can you measure the ROI of medical device sales training? Mark Wilson is the Director of Training and Development for Advanced Biohealing. In this interview, he tells us why medical device sales training is vastly underrated and why you should be paying closer attention to it.
INTERVIEW HIGHLIGHTS WITH MARK WILSON
- The importance of immersing yourself in the business in order to build an effective medical device training program.
- Why the sales training role should NOT be viewed as a transition or developmental position.
- How to convince senior leadership that sales training is essential to business development.
- What Mark means by “training is leading from behind”.
- Mark’s tips for developing a mobile learning strategy.
- Mark’s advice for medical device doers. Hint: Check your passion bucket.
- And much more!
DOWNLOAD THE INTERVIEW WITH MARK WILSON
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
WHO IS MARK WILSON?
Mark Wilson is the Director of Training and Development for Advanced Biohealing, a Shire company. He was formerly the Director of Sales Training and Development for Bard Peripheral Vascular, a division of CR Bard. Connect with Mark on LinkedIn or follow him on Twitter. Have questions for Mark? Email him at [email protected].
